Literature DB >> 1845562

Connective tissue metabolism and alcohol intake in alcoholic liver disease.

O Niemelä1, J Risteli, J E Blake, L Risteli, K V Compton, H Orrego.   

Abstract

We have examined the relationship between blood markers of fibrogenesis and basement membrane formation and alcohol intake in patients with a wide range of clinical and histological severity of alcoholic liver disease (Niemelä et al., 1990). While the patients with a mean of less than 8 mM alcohol in morning urines (mild or moderate drinkers) had a significant (p < 0.00001) decrease in serum aminoterminal propeptide of type III procollagen, type IV collagen and laminin in a period of 27 +/- 1 weeks, the patients with more than 8 mM of urinary alcohol (heavy drinkers) had no improvement. There was also a significant decrease in serum gamma glutamyl transferase activity in the group with lower, but not in that with the higher urinary alcohol concentrations. The Combined Clinical and Laboratory Index (CCLI) decreased in both groups, although the recovery was significantly (p < 0.03) greater in those with the lower urinary alcohol levels (66% +/- 6%) than in the group with a urinary alcohol level of > or = 8 mM (28% +/- 15%). We suggest that connective tissue metabolism in alcoholic liver disease is closely related to alcohol intake and thus affects the prognosis of the alcoholic patient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845562

Source DB:  PubMed          Journal:  Alcohol Alcohol Suppl        ISSN: 1358-6173


  2 in total

1.  Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease.

Authors:  F Stickel; R Urbaschek; D Schuppan; G Poeschl; C Oesterling; C Conradt; R S McCuskey; U A Simanowski; H K Seitz
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

2.  Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease.

Authors:  Satoshi Mamori; Yasuyuki Searashi; Masato Matsushima; Kenichi Hashimoto; Shinichiro Uetake; Hiroshi Matsudaira; Shuji Ito; Hisato Nakajima; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.